1 study found for:    20082117 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Comparison Study of MDX-010 (CTLA-4) Alone and Combined With DTIC in the Treatment of Metastatic Melanoma
Condition: Melanoma
Intervention: Drug: MDX-010 (CTLA-4)

Indicates status has not been verified in more than two years